BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8435099)

  • 1. Inhibition of phospholipase C delta by hexadecylphosphorylcholine and lysophospholipids with antitumor activity.
    Pawelczyk T; Lowenstein JM
    Biochem Pharmacol; 1993 Jan; 45(2):493-7. PubMed ID: 8435099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of phospholipase C delta activity by sphingomyelin and sphingosine.
    Pawelczyk T; Lowenstein JM
    Arch Biochem Biophys; 1992 Sep; 297(2):328-33. PubMed ID: 1497353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of different molecular species of sphingomyelin on phospholipase C delta 1 activity.
    Pawelczyk T; Lowenstein JM
    Biochimie; 1997 Dec; 79(12):741-8. PubMed ID: 9523016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of sphingomyelin and its metabolites on the activity of human recombinant PLC delta 1.
    Matecki A; Stopa M; Was A; Pawelczyk T
    Int J Biochem Cell Biol; 1997 May; 29(5):815-28. PubMed ID: 9251249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of phospholipase C-beta in the modulation of epithelial tight junction permeability.
    Ward PD; Ouyang H; Thakker DR
    J Pharmacol Exp Ther; 2003 Feb; 304(2):689-98. PubMed ID: 12538823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hexadecylphosphocholine inhibits phosphatidylinositol and phosphatidylcholine phospholipase C in human leukemia cells.
    Berkovic D; Goeckenjan M; Lüders S; Hiddemann W; Fleer EA
    J Exp Ther Oncol; 1996 Sep; 1(5):302-11. PubMed ID: 9414418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of phosphatidylinositol-specific phospholipase C by HDL-associated lysosphingolipid. Involvement in mitogenesis but not in cholesterol efflux.
    Nofer JR; Fobker M; Höbbel G; Voss R; Wolinska I; Tepel M; Zidek W; Junker R; Seedorf U; von Eckardstein A; Assmann G; Walter M
    Biochemistry; 2000 Dec; 39(49):15199-207. PubMed ID: 11106499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel role of phospholipase C-delta1: regulation of liver mitochondrial Ca2+ uptake.
    Knox CD; Belous AE; Pierce JM; Wakata A; Nicoud IB; Anderson CD; Pinson CW; Chari RS
    Am J Physiol Gastrointest Liver Physiol; 2004 Sep; 287(3):G533-40. PubMed ID: 15107298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysophosphatidylcholine stimulates interleukin-6 release from rat anterior pituitary cells in vitro.
    Spangelo BL; Jarvis WD
    Endocrinology; 1996 Oct; 137(10):4419-26. PubMed ID: 8828503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural requirements of phospholipase C delta1 for regulation by spermine, sphingosine and sphingomyelin.
    Pawelczyk T; Matecki A
    Eur J Biochem; 1997 Sep; 248(2):459-65. PubMed ID: 9346303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is metabolism an important arbiter of anticancer activity of ether lipids? Metabolism of SRI 62-834 and hexadecylphosphocholine by [31P]-NMR spectroscopy and comparison of their cytotoxicities with those of their metabolites.
    Bishop FE; Dive C; Freeman S; Gescher A
    Cancer Chemother Pharmacol; 1992; 31(2):85-92. PubMed ID: 1451237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of phospholipase C beta, gamma, and delta families alters cell growth and phosphatidylinositol 4,5-bisphosphate levels.
    Nebigil CG
    Biochemistry; 1997 Dec; 36(50):15949-58. PubMed ID: 9398329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of lysophospholipids related to the hamster sperm acrosome reaction in vitro.
    Llanos MN; Morales P; Riffo MS
    J Exp Zool; 1993 Oct; 267(2):209-16. PubMed ID: 8409901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of phospholipase C-delta 1 catalytic activity by sphingomyelin.
    Scarlata S; Gupta R; Garcia P; Keach H; Shah S; Kasireddy CR; Bittman R; Rebecchi MJ
    Biochemistry; 1996 Nov; 35(47):14882-8. PubMed ID: 8942652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of PLC-gamma1 activity converts nerve growth factor from an anti-mitogenic to a mitogenic signal in CHO cells.
    Zapf-Colby A; Eichhorn J; Webster NJ; Olefsky JM
    Oncogene; 1999 Sep; 18(35):4908-19. PubMed ID: 10490825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical evidence for the role of alkyl-lysophospholipids on liver sialyltransferase.
    Bador H; Morelis R; Louisot P
    Int J Biochem; 1983; 15(9):1137-42. PubMed ID: 6684598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of transmembrane ion transport by reaction products of phospholipase A2. I. Effects of lysophospholipids on mitochondrial Ca2+ transport.
    Lenzen S; Görlich JK; Rustenbeck I
    Biochim Biophys Acta; 1989 Jun; 982(1):140-6. PubMed ID: 2472836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alkylphosphocholines: a new class of membrane-active anticancer agents.
    Hilgard P; Klenner T; Stekar J; Unger C
    Cancer Chemother Pharmacol; 1993; 32(2):90-5. PubMed ID: 8485813
    [No Abstract]   [Full Text] [Related]  

  • 19. Modulation of phospholipase D by hexadecylphosphorylcholine: a putative novel mechanism for its antitumoral activity.
    Lucas L; Hernández-Alcoceba R; Penalva V; Lacal JC
    Oncogene; 2001 Mar; 20(9):1110-7. PubMed ID: 11314048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression, purification and kinetic properties of human recombinant phospholipase C delta 3.
    Pawełczyk T; Matecki A
    Acta Biochim Pol; 1997; 44(2):221-9. PubMed ID: 9360711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.